Faulty Dengue Vaccine Resulting in Deaths and Increased Diseases in Philippines Seeks FDA Approval for U.S. Market

Health Impact News reported late last year (December 2017) that vaccine manufacturer Sanofi Pasteur admitted that their vaccine for dengue (a deadly tropical disease spread mostly by mosquitoes) was defective. In a press release from France, the pharmaceutical company admitted that the vaccine is harmful to those not previously infected with dengue, and could cause children not previously infected with dengue to contract a severe case of the disease. More than 800,000 Filipino children have received at least one dose of Dengvaxia. Former Philippine President Benigno Aquino III stated recently that he would not have approved a mass immunization program in 2015 using Dengvaxia had Sanofi Pasteur, the French pharmaceutical company that developed the dengue vaccine, made known then that the drug posed risks to the health of some people. Reports of severe cases of Dengue and even some deaths have been related to the Dengvaxia vaccine, and the Philippine Department of Health (DOH) has setup "express lanes" at local hospitals to deal with illnesses and injuries due to the vaccine. In the vaccine marketing trade publication FiercePharma, it is being reported that Sanofi is not going to let the "Dengvaxia mess" in the Philippines stop them from seeking FDA approval for the vaccine to be sold in the U.S.

730,000 Filipino Children Receive Faulty Dengue Vaccine Which Causes Dengue Rather Than Preventing it

In a story that is being mostly censored in the U.S. media, vaccine manufacturer Sanofi Pasteur has admitted that their vaccine for dengue (a deadly tropical disease spread mostly by mosquitoes) is defective. In a press release from France, the pharmaceutical company admitted that the vaccine is harmful to those not previously infected with dengue, and could cause children not previously infected with dengue to contract a severe case of the disease. The Philippines was the first country in Asia to approve the vaccine for individuals aged 9 and 45 years old in December 2015. More than 730,000 Filipino children have received at least one dose of Dengvaxia, the first licensed vaccine for the virus, since the Philippine Department of Health launched the vaccination drive in schools last year.

No Polio in the Philippines Since 1993, But Mass Polio Vaccination Program Targeted for 500,000 Typhoon Victims Under Age 5

In spite of the fact that there have been no cases of polio in the Philippines since 1993, WHO and UNICEF are taking advantage of the typhoon tragedy to spread their vaccine program into the Philippines, administering the highly controversial and dangerous oral live attenuated polio vaccine, which is no longer used in the U.S., but is still common in poorer countries. 30,000 children have already been vaccinated in an extraordinary effort in the typhoon aftermath, and 500,000 children under the age of five are targeted for the live polio vaccine and the measles vaccine. Will the Philippines now be added to the list of countries where UNICEF works that sees an increase in infant mortality under the age of five? How many Filipino children will now be sacrificed for the vaccine cause, in a country that has no polio and where measles has been declining and is rare?